Abstract:Abstract Basal cell carcinomas (BCCs) are slow-growing keratinocyte tumours. During the COVID-19 pandemic, the British Association of Dermatologists and British Society for Dermatological Surgery recommended deferment of surgical treatment for BCCs by 3–6 months unless they were causing significant symptoms or were at higher risk of growth. The deferment of surgical treatment for BCCs provided an unexpected opportunity to evaluate the natural history of BCC evolution given the paucity of evidence and conflicting outcomes of published literature. This study evaluated the natural progression of BCCs while awaiting surgical intervention, to better understand their natural growth and development. We also examined whether delays in surgery had implications on clinical outcomes. Patients with a suspected diagnosis of BCC, who had a surgical procedure planned between February and April 2023, were included in the data collection. Retrospective analysis was performed on the data, including waiting time for surgery, subtype of BCC, the size of the lesion, the location of the lesion, the planned and actual surgery performed and the patients’ symptomatology. Fifty-five patients, with a total of 70 lesions, were included in this analysis. Fifty lesions were found on the face and the others were on the trunk or limbs. The mean sum of BCC size was 91.7 mm2, while a larger mean size of BCCs of 119 mm2 was found on the trunk and limbs compared with the face (mean size 80.8 mm2). Twenty per cent of the cases had a larger procedure than originally planned at the time of booking. A regression analysis showed 0.36 mm2 in growth on average (P < 0.002), and 0.0045% (P < 0.002) each day since presentation. Both values are statistically significant. A positive relationship between growth and time between presentation and surgical appointment (multiple R of 0.36) was demonstrated. The top three symptoms reported include itching (39%), crusting (36%) and bleeding (30%). In conclusion, our data reveal that while awaiting a surgical intervention, a BCC is likely to increase in size. Patients can therefore end up with larger and more complex procedures than originally planned. The symptoms experienced by patients should also be taken into consideration when planning surgery. Traditionally BCCs are not prioritized on a dermatology surgical list, compared with other skin cancers, but our findings demonstrate that a delay in surgical intervention can result in larger procedures being performed, and as a consequence increased morbidity to patients with greater impact on their quality of life.

P051 The what, how and why of basal cell carcinoma: natural progression and surgical intervention